BSE Live
Jun 09, 16:01Prev. Close
951.25
Open Price
954.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jun 09, 15:58Prev. Close
951.85
Open Price
955.00
Bid Price (Qty.)
959.55 (159)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Gland Pharma (in Rs. Cr.) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 3,616.53 | 4,384.15 | 3,423.64 | 2,571.78 | 1,993.15 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 3,616.53 | 4,384.15 | 3,423.64 | 2,571.78 | 1,993.15 | |
Total Operating Revenues | 3,616.53 | 4,400.71 | 3,462.88 | 2,633.24 | 2,044.20 | |
Other Income | 240.46 | 223.94 | 134.78 | 139.17 | 85.56 | |
Total Revenue | 3,856.99 | 4,624.65 | 3,597.65 | 2,772.41 | 2,129.77 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 1,716.75 | 2,046.86 | 1,749.16 | 1,090.25 | 954.89 | |
Purchase Of Stock-In Trade | 15.59 | 25.67 | 16.20 | 18.67 | 16.28 | |
Operating And Direct Expenses | 0.00 | 95.05 | 74.59 | 78.50 | 74.03 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -46.92 | 36.69 | -273.49 | -6.90 | -114.15 | |
Employee Benefit Expenses | 399.70 | 338.57 | 311.36 | 277.66 | 222.95 | |
Finance Costs | 7.41 | 5.24 | 3.41 | 7.18 | 3.56 | |
Depreciation And Amortisation Expenses | 146.74 | 110.30 | 98.78 | 94.59 | 81.96 | |
Other Expenses | 512.85 | 347.23 | 282.79 | 219.59 | 183.89 | |
Total Expenses | 2,752.13 | 3,005.61 | 2,262.80 | 1,779.54 | 1,423.41 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1,104.86 | 1,619.04 | 1,334.85 | 992.87 | 706.36 | |
Exceptional Items | -56.46 | 0.00 | 0.00 | 0.00 | -20.00 | |
Profit/Loss Before Tax | 1,048.40 | 1,619.04 | 1,334.85 | 992.87 | 686.36 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 272.58 | 395.88 | 339.45 | 251.40 | 221.23 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | 14.01 | 0.12 | -31.82 | 12.00 | |
Tax For Earlier Years | 0.00 | -3.00 | -1.72 | 0.43 | 1.23 | |
Total Tax Expenses | 272.58 | 406.89 | 337.85 | 220.01 | 234.45 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 775.83 | 1,212.16 | 997.01 | 772.86 | 451.91 | |
Profit/Loss From Continuing Operations | 775.83 | 1,212.16 | 997.01 | 772.86 | 451.91 | |
Profit/Loss For The Period | 775.83 | 1,212.16 | 997.01 | 772.86 | 451.91 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 47.12 | 73.84 | 63.07 | 49.88 | 29.16 | |
Diluted EPS (Rs.) | 47.11 | 73.67 | 62.99 | 49.88 | 29.16 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
18.05.2023
Gland Standalone March 2023 Net Sales at Rs 785.42 crore, down 28.79% Y-o-Y
18.05.2023
Gland Consolidated March 2023 Net Sales at Rs 785.01 crore, down 28.83% Y-o-Y
23.01.2023
Gland Standalone December 2022 Net Sales at Rs 925.90 crore, down 12.92% Y-o-Y
23.01.2023
Gland Consolidated December 2022 Net Sales at Rs 938.29 crore, down 11.76% Y-o-Y